TBIO-11. The glutamine transporter and candidate diagnostic and therapeutic target SLC1A5 is associated with subtype-specific metabolic phenotypes and tumor prognosis in pediatric brain cancers
Author(s) -
Adam Kraya,
Run Jin,
Chao Zhao,
Ariana Familiar,
Kathryn E. Wellen,
Adam Resnick,
Ali Nabavizadeh
Publication year - 2022
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noac079.693
Subject(s) - glutamine , amino acid transporter , transporter , brain tumor , biology , cancer research , phenotype , ependymoma , solute carrier family , glioma , transcriptome , amino acid , medicine , pathology , gene expression , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom